Bilirubin neurotoxicity is associated with proteasome inhibition
Hongbiao Huang(Guangzhou Medical University Cancer Hospital), Jinbao Liu(State Key Laboratory of Respiratory Disease)
Cited by 37
Related Papers
Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth
|Oncotarget|2014|170
Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor
|Cell Death and Disease|2017|118
Inhibition of USP14 enhances the sensitivity of breast cancer to enzalutamide
|Journal of Experimental & Clinical Cancer Research|2019|102
Inhibition of EGFR signaling with Spautin-1 represents a novel therapeutics for prostate cancer
|Journal of Experimental & Clinical Cancer Research|2019|101
Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer
|Cell Death and Disease|2017|97